Literature DB >> 19696787

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

N R Christoffersen1, R Shalgi, L B Frankel, E Leucci, M Lees, M Klausen, Y Pilpel, F C Nielsen, M Oren, A H Lund.   

Abstract

Aberrant oncogene activation induces cellular senescence, an irreversible growth arrest that acts as a barrier against tumorigenesis. To identify microRNAs (miRNAs) involved in oncogene-induced senescence, we examined the expression of miRNAs in primary human TIG3 fibroblasts after constitutive activation of B-RAF. Among the regulated miRNAs, both miR-34a and miR-146a were strongly induced during senescence. Although members of the miR-34 family are known to be transcriptionally regulated by p53, we find that miR-34a is regulated independently of p53 during oncogene-induced senescence. Instead, upregulation of miR-34a is mediated by the ETS family transcription factor, ELK1. During senescence, miR-34a targets the important proto-oncogene MYC and our data suggest that miR-34a thereby coordinately controls a set of cell cycle regulators. Hence, in addition to its integration in the p53 pathway, we show that alternative cancer-related pathways regulate miR-34a, emphasising its significance as a tumour suppressor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696787     DOI: 10.1038/cdd.2009.109

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  162 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  microRNA-34c is a novel target to treat dementias.

Authors:  Athanasios Zovoilis; Hope Y Agbemenyah; Roberto C Agis-Balboa; Roman M Stilling; Dieter Edbauer; Pooja Rao; Laurent Farinelli; Ivana Delalle; Andrea Schmitt; Peter Falkai; Sanaz Bahari-Javan; Susanne Burkhardt; Farahnaz Sananbenesi; Andre Fischer
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

3.  Signatures of RNA binding proteins globally coupled to effective microRNA target sites.

Authors:  Anders Jacobsen; Jiayu Wen; Debora S Marks; Anders Krogh
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

Review 4.  Regulation of mammalian microRNA expression.

Authors:  Xiaoxiao Zhang; Yan Zeng
Journal:  J Cardiovasc Transl Res       Date:  2010-02-20       Impact factor: 4.132

Review 5.  Invited review: decoding the microRNA response to hypoxia.

Authors:  Roger Pocock
Journal:  Pflugers Arch       Date:  2011-01-05       Impact factor: 3.657

Review 6.  Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.

Authors:  Dahong Yao; Yingnan Jiang; Suyu Gao; Lei Shang; Yuqian Zhao; Jian Huang; Jinhui Wang; Shilin Yang; Lixia Chen
Journal:  Cell Prolif       Date:  2016-07-20       Impact factor: 6.831

7.  The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.

Authors:  Francesca R Dejure; Nadine Royla; Steffi Herold; Jacqueline Kalb; Susanne Walz; Carsten P Ade; Guido Mastrobuoni; Jens T Vanselow; Andreas Schlosser; Elmar Wolf; Stefan Kempa; Martin Eilers
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

8.  Argonaute protein as a linker to command center of physiological processes.

Authors:  Kaifa Wei; Lingjuan Wu; Yanhui Chen; Yina Lin; Yanmei Wang; Xiaoyao Liu; Daoxin Xie
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

9.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

10.  MicroRNA-34a regulates cardiac ageing and function.

Authors:  Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.